Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY: LLY )

298.85 +12.58 (+4.39%)
Official Closing Price Updated: 4:10 PM EDT, May 20, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Eli Lilly

< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
The Daily Biotech Pulse: Big Pharma Earnings Prove Lackluster, Mersana Inks $1B ADC R&D Deal, Syros Gets Orphan Drug Designation
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
Eli Lilly: Q4 Earnings Insights
  Eli Lilly (NYSE:LLY) reported its Q4 earnings results on Thursday, February 3, 2022 at 06:25 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Earnings Scheduled For February 3, 2022
Companies Reporting Before The Bell • Tuesday Morning (NASDAQ:TUEM) is likely to report earnings for its second quarter. 
Via Benzinga
A Preview Of Eli Lilly's Earnings
Eli Lilly (NYSE:LLY) is set to give its latest quarterly earnings report on Thursday, 2022-02-03. Here's what investors need to know before the announcement. Analysts estimate that Eli Lilly will... 
Via Benzinga
Looking At Eli Lilly's Recent Whale Trades
Benzinga's options scanner just detected over 12 options trades for Eli Lilly (NYSE:LLY) summing a total amount of $597,272. At the same time, our algo caught 7 for a total amount of 518,954. 
Via Benzinga
Attention Biotech Investors: Mark Your Calendar For These Key February PDUFA Dates
After a fairly robust 2021, the new year started on a mixed note as far as regulatory decisions are concerned. 
Via Benzinga
Lilly To Inject $1B In New Manufacturing Facility In North Carolina, US
Eli Lilly And Co (NYSE: LLY)  
Via Benzinga
Eli Lilly Plans To Invest €400M In Manufacturing Facility In Ireland: Report
Eli Lilly And Co (NYSE: LLY) plans to invest more than €400 million into a new manufacturing facility in Limerick, Ireland, according to a 
Via Benzinga
The Week Ahead In Biotech (Jan 31-Feb 5): Merck, Bristol-Myers Squibb, Lilly & Novartis Headline Large-Cap Biopharma Earnings News
The broader market weakness pervaded into the biotech sector in the week ending Jan. 28, sending stocks lower. 
Via Benzinga
Eli Lilly Expects FDA Rejection For Expanded Use Baricitinib For Eczema
Based on top-line efficacy results from two pivotal Phase 3 trials Eli Lilly And Co (NYSE: LLY) has decided to  
Via Benzinga
What Are Whales Doing With Eli Lilly
A whale with a lot of money to spend has taken a noticeably bullish stance on Eli Lilly. Looking at options history for Eli Lilly (NYSE:LLY) we detected 13 strange trades. If we... 
Via Benzinga
A Peek Into The Markets: US Stock Futures Mostly Lower Ahead Of Earnings, Fed Meeting
Pre-open movers U.S. stock futures traded mostly lower in early pre-market trade. The Dow Jones settled higher by around 100 points on Monday after tumbling more than 1,000 points... 
Via Benzinga
Expert Ratings For Eli Lilly
Over the past 3 months, 7 analysts have published their opinion on Eli Lilly (NYSE: 
Via Benzinga
FDA Rescinds Authorization For Regeneron, Eli Lilly COVID-19 Antibody Treatments: Here's Why
Antibody treatments made by Regeneron Pharmaceuticals Inc (NASDAQ: REGN) and Eli Lilly And Co (NYSE: LLY) are not likely to work against the Omicron variant of COVID-19 and their... 
Via Benzinga
Analysis: Why Is It So Difficult To Obtain COVID-19 Monoclonal Antibody Treatments?
The demand for monoclonal antibody treatments to help in the recovery of COVID-19 patients has outpaced the supply, and this situation runs the risk of becoming more acute as... 
Via Benzinga
If You Invested $1000 In This Stock 5 Years Ago, Here's How Much You Would Have Today
Eli Lilly (NYSE:LLY) has outperformed the market over the past 5 years by 12.31% on an annualized basis. Buying $1,000 In LLY: 5 years ago, an investor could have purchased 13.41... 
Via Benzinga
Week In Review: Mabwell Bio Raises $547 Million In Shanghai STAR IPO
Mabwell Bioscience completed a $547 million IPO on Shanghai's STAR Board. Abbisko Therapeutics formed a global collaboration worth up to $258 million with Lilly to continue discovery and development of... 
Via Talk Markets
Looking Into Eli Lilly and Company's Recent Short Interest
Eli Lilly and Company's (NYSE:LLY) short percent of float has risen 4.0% since last its last report. The company recently reported that it has 6.19 million shares sold short,... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 21, 2022
Upgrades According to Seaport Global, the prior rating for KB Home (NYSE: 
Via Benzinga
Looking At Eli Lilly's Recent Whale Trades
A whale with a lot of money to spend has taken a noticeably bearish stance on Eli Lilly. Looking at options history for Eli Lilly (NYSE:LLY) we detected 11 strange trades. If we... 
Via Benzinga
World Markets News
Today oil and gas inventories were seen as higher than expected while potential prices fell, both bullish. 
Via Talk Markets
Everest Boosts Covid Bet With New Licensing Deal Despite Crowded Field
Key Takeaways Everest has signed a global licensing deal for an anti-viral Covid treatment being developed by Singapore’s Experimental Drug Development Centre Similar oral... 
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our... 
Via Benzinga
Wednesday File
It sound odd but the real threat to markets is slowing Chinese growth which fell to 4% in Q4 from double that earlier last year. 
Via Talk Markets
Chopped Stocks
The day's theme is sell tech and buy banks. 
Via Talk Markets
7 of the Top-Rated Pharmaceutical Stocks for Q1
As the market begins to shift from high-growth, tech-fueled start-ups, one good long-term growth option is quality pharmaceutical stocks. 
Via InvestorPlace
Abbisko, Lilly Ink Licensing Pact For Cardiometabolic Diseases
Abbisko Therapeutics has entered into a worldwide collaboration and exclusive licensing agreement with Eli Lilly And Co (NYSE: LLY) for novel molecules against an... 
Via Benzinga
More Serious Matters
Wall Street fell on new worries about inflation and a drop in retail sales levels. 
Via Talk Markets
WHO Recommends Glaxo, Eli Lilly Drugs For COVID-19 Treatment Amid Omicron Surge
An expert panel at the World Health Organization (WHO) recommended the use of treatments developed by Eli Lilly And Co (NYSE: LLY) and GlaxoSmithKline Plc... 
Via Benzinga
Two Curses Of The Current Year
The good news on inflation after this week's shocker is that December wholesale prices only rose 0.2%. 
Via Talk Markets
< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.